Skip to main content
. 2022 Sep 7;10:962959. doi: 10.3389/fbioe.2022.962959

TABLE 3.

Mean ± standard deviation of VAF values for the reconstruction of measured muscle excitations with muscle synergy analysis across both subjects and all calibration trials with four to seven synergies when unmeasured synergy vector weights were assumed to be trial-specific, speed specific, or subject-specific.

Sub Variability assumption Left Right
Number of synergies Number of synergies
4 5 6 7 4 5 6 7
S1 Trial 96.5 ± 1.5 98.2 ± 0.7 99.3 ± 0.3 99.7 ± 0.1 95.2 ± 2.4 96.8 ± 1.8 98.6 ± 0.9 99.2 ± 0.5
Speed 91.0 ± 3.6 93.7 ± 2.2 96.1 ± 1.5 97.4 ± 1.1 87.7 ± 5.6 92.2 ± 3.8 94.3 ± 2.5 95.5 ± 2.0
Subject 89.2 ± 5.6 92.1 ± 3.3 94.8 ± 2.6 96.2 ± 1.6 84.4 ± 7.1 88.5 ± 3.6 92.2 ± 4.4 95.1 ± 3.3
S2 Trial 95.3 ± 1.8 97.6 ± 1.2 98.8 ± 0.6 99.5 ± 0.2 97.3 ± 1.1 98.6 ± 0.5 99.3 ± 0.3 99.6 ± 0.2
Speed 89.3 ± 4.1 93.2 ± 2.6 93.2 ± 2.6 97.1 ± 0.9 95.3 ± 0.9 96.5 ± 0.9 97.3 ± 0.7 97.9 ± 0.4
Subject 87.8 ± 4.5 91.3 ± 2.7 94.7 ± 1.9 96.0 ± 1.7 93.1 ± 1.4 95.4 ± 0.8 96.3 ± 0.7 97.1 ± 0.8

Sub. means subject bold represents the minimum number of synergies required for the specific leg to achieve a VAF above 95%.